CSR preparation remains one of the most manual processes in drug development. The case for software-assisted automation in regulatory...
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.
























































